 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Clinical profile and outcomes of opioid abuse gastroenteropathy: an underdiagnosed disease entity |
| Ramit Mahajan, Yogesh Gupta, Arshdeep Singh, Pulkit Dhiman, Vandana Midha, Chandan Kakkar, Vikram Narang, Varun Mehta, Kavita Saggar, Ajit Sood |
|
Intest Res. 2020;18(2):238-244. Published online February 25, 2020 DOI: https://doi.org/10.5217/ir.2019.00104 |
|
Clinical profile and outcomes of opioid abuse gastroenteropathy: an underdiagnosed disease entity Intestinal Research. 2020;18(2):238-244  Corrigendum: The effect of an abuse-deterrent opioid formulation (OxyContin) on opioid abuse-related outcomes in the postmarketing setting Clinical Pharmacology & Therapeutics. 2017;101(4):541-541 Discrepant Hemophilia A: An Underdiagnosed Disease Entity American Journal of Clinical Pathology. 2020;154(1):78-87 Renal Athero-embolic Disease: An Underdiagnosed Entity in Cardiac Catheterization Kidney Disease in the Cardiac Catheterization Laboratory. 2020;275-284 Rapid eye movement sleep behaviour disorder in women with Parkinson’s disease is an underdiagnosed entity Journal of Clinical Neuroscience. 2016;28:43-46 Postconcussion Syndrome: A Complex and Underdiagnosed Clinical Entity World Neurosurgery. 2014;82(5):627-628 Cholesterol embolism: An underdiagnosed clinical entity American Heart Journal. 1992;124(5):1321-1326 PTSD affects treatment outcomes in opioid abuse PharmacoEconomics & Outcomes News. 2005;488(1):5-5 Lymphadenopathy of IgG4-related disease: an underdiagnosed and overdiagnosed entity Seminars in Diagnostic Pathology. 2012;29(4):226-234 Buprenorphine/naloxone cost effective for opioid abuse PharmacoEconomics & Outcomes News. 2019;819(1):12-12 |
